Literature DB >> 12843700

Measurement of protein synthesis and degradation in C2C2) myoblasts using extracts of muscle from hormone treated bovine.

J L Montgomery1, W M Harper, M F Miller, K J Morrow, J R Blanton.   

Abstract

A detailed methodology is described for determination of treatment effects on muscle cell protein synthesis and muscle cell protein degradation in a cell culture system. C(2)C(22) mouse myoblasts were treated with growth media containing muscle extracts from bovine treated with different pharmaceutical agents. Radiolabeled amino acids were added to the growth media to determine treatment effects on protein synthesis and protein degradation. Percent protein synthesis was calculated by measuring amino acid uptake as a percentage over internal control. Percent protein degradation was measured using a pulse chase technique. These procedures will allow researchers to determine treatment effects on overall protein synthesis and degradation in vitro in a relatively short amount of time without excessive costs. A second benefit is that animals do not have to be fed radiolabeled feedstuffs. These procedures are not intended to elucidate the mechanisms behind pharmaceutical enhancement of muscle cell protein synthesis or protein degradation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12843700     DOI: 10.1023/a:1024498316958

Source DB:  PubMed          Journal:  Methods Cell Sci        ISSN: 1381-5741


  3 in total

1.  Akt-dependent anabolic activity of natural and synthetic brassinosteroids in rat skeletal muscle cells.

Authors:  Debora Esposito; Thirumurugan Rathinasabapathy; Alexander Poulev; Slavko Komarnytsky; Ilya Raskin
Journal:  J Med Chem       Date:  2011-05-26       Impact factor: 7.446

2.  Anabolic effect of plant brassinosteroid.

Authors:  Debora Esposito; Slavko Komarnytsky; Sue Shapses; Ilya Raskin
Journal:  FASEB J       Date:  2011-07-11       Impact factor: 5.191

3.  Resveratrol inhibits protein translation in hepatic cells.

Authors:  Eugenia Villa-Cuesta; Joan M Boylan; Marc Tatar; Philip A Gruppuso
Journal:  PLoS One       Date:  2011-12-29       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.